Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
Mohamed L. Sorror(University of Washington Medical Center), David G. Maloney(Fred Hutch Cancer Center), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Amelia Langston(CancerCare Manitoba), Barry E. Storer(City Of Hope National Medical Center), Richard T. Maziarz(Oregon Health & Science University), Brenda M. Sandmaier(University of Washington), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jerald P. Radich(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Edward Agura(Baylor University), Karl G. Blume(City Of Hope National Medical Center), Michael B. Maris(Colorado Blood Cancer Institute), Michael A. Pulsipher(Primary Children's Hospital), James C. Wade(Medizinische Hochschule Hannover), Judith A. Shizuru(Stanford University)
Cited by 278
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k